Responses
Dermatology
Protocol
Study protocol of the global Effisayil 1 Phase II, multicentre, randomised, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis presenting with an acute flare
Compose a Response to This Article
Other responses
No responses have been published for this article.